跳至主要内容
临床试验/NCT03230682
NCT03230682Unknown不适用

Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder

Huashan Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年7月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Early improvement

研究概览

简要总结

Early improvemrnt, decreased 20% in the 17 items of Hamilton Depression Rating Scale (HAMD-17) at the second week of the treatment of major depression disorder (MDD), can arguably predict the remission at the 12th week. Our observation study including 80 MDD patients will access resting-state function MRI to finding factors which infuencing early improvemrnt, respone and remission of antidepressants.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • right-handed; HAMD-17 more than 17; diagnosed with MDD by the Structured Clinical Interview for DSM-IV

排除标准

  • patients diagnosed with other condition in DSM-IV Axis I; pregnency; Thyroid disease; Heart Disease

研究组 & 干预措施

major depressive disorder

干预措施: antidepressant (Drug)

结局指标

主要结局

Early improvement

时间窗: the second week of treatment

obtain 20% decrease of HAMD-17

次要结局

  • Response(the 12th week of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianhui Fu

Department of Neurology, Huashan Hospital

Huashan Hospital

研究点 (1)

Loading locations...

相似试验

Eealy Improvement Predicts Antidepressants Response... | 临床试验